Literature DB >> 18821494

Case files of the University of Massachusetts fellowship in medical toxicology: lethal dose of opioids contained in an elastomeric capsule labeled as vancomycin.

James Courtney1, Edward Boyer.   

Abstract

UNLABELLED: A 67 year-old male presented to the emergency department with alteration in mental status. On arrival he had vital signs: pulse 110, BP 173/83, respiratory rate 4, oxygen saturation 57% and temperature 36.1 degrees Celsius. His past medical history included hypertension, vitamin B12 deficiency, hyperlipidemia, and recurrent cellulitis treated with vancomycin. The patient had no response to noxious stimuli, pinpoint pupils, and agonal respirations. Secondary to his wife's vehement denial that he had access to or history of using any narcotics, he was intubated after 2.2mg IV naloxone failed to reverse respiratory depression. Thirty minutes before presentation, however, he had received an intravenous infusion of vancomycin administered by his wife at home. The vancomycin, obtained from a home infusion medication supply company, was contained in one of five sealed elastomeric capsules delivered earlier that day. A qualitative comprehensive toxicology screen of urine for 1043 substances identified morphine, codeine, naloxone, lidocaine and caffeine. The original elastomeric container was not available for testing, but another container from the same delivery was submitted for testing to the state forensic laboratory. This intact container was labeled as Vancomycin 1g in 240mL of normal saline. The forensic laboratory confirmed that the alkaloidal contents of the elastomeric capsule were 10% codeine, 4.4% 6-monoacetyl morphine, and 84% morphine. No vancomycin was identified in the infusion bottles. The case was referred to the local police department and the state department of health drug control board. The home infusion company was also immediately notified to prevent similar occurrence.
CONCLUSION: We are reporting the first known case of opioid overdose from an adulterated elastomeric capsule that was labeled as containing an antimicrobial agent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18821494      PMCID: PMC3550037          DOI: 10.1007/bf03161200

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  27 in total

1.  The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: data from the Outpatient Parenteral Antimicrobial Therapy Outcomes Registries.

Authors:  A Tice
Journal:  Chemotherapy       Date:  2001       Impact factor: 2.544

2.  Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.

Authors:  S Kim; H N Wagner; V L Villemagne; P F Kao; R F Dannals; H T Ravert; T Joh; R B Dixon; A C Civelek
Journal:  J Nucl Med       Date:  1997-11       Impact factor: 10.057

3.  Experience of infectious diseases consultants with outpatient parenteral antimicrobial therapy: results of an emerging infections network survey.

Authors:  Aarthi Chary; Alan D Tice; Lawrence P Martinelli; Laura A Liedtke; Melissa S Plantenga; Larry J Strausbaugh
Journal:  Clin Infect Dis       Date:  2006-10-10       Impact factor: 9.079

4.  A 'cold synthesis' of heroin and implications in heroin signature analysis utility of trifluoroacetic/acetic anhydride in the acetylation of morphine.

Authors:  Luke R Odell; Jana Skopec; Adam McCluskey
Journal:  Forensic Sci Int       Date:  2006-03-23       Impact factor: 2.395

5.  Validity and reliability of the Neurobehavioral Assessment Scale.

Authors:  D A Chernik; M Tucker; B Gigli; K Yoo; K Paul; H Laine; J L Siegel
Journal:  J Clin Psychopharmacol       Date:  1992-02       Impact factor: 3.153

6.  Systematic review of factors affecting the ratios of morphine and its major metabolites.

Authors:  Clara C Faura; Sally L Collins; Andrew R Moore; Henry J McQuay
Journal:  Pain       Date:  1998-01       Impact factor: 6.961

7.  Diamorphine stability in aqueous solution for subcutaneous infusion.

Authors:  O A Omar; P J Hoskin; A Johnston; G W Hanks; P Turner
Journal:  J Pharm Pharmacol       Date:  1989-04       Impact factor: 3.765

8.  The effect of temperature and pH on the deacetylation of diamorphine in aqueous solution and in human plasma.

Authors:  D A Barrett; A L Dyssegaard; P N Shaw
Journal:  J Pharm Pharmacol       Date:  1992-07       Impact factor: 3.765

9.  Continuous naloxone infusion in pediatric narcotic overdose.

Authors:  J M Lewis; W Klein-Schwartz; B E Benson; G M Oderda; S Takai
Journal:  Am J Dis Child       Date:  1984-10

10.  A dosing nomogram for continuous infusion intravenous naloxone.

Authors:  L Goldfrank; R S Weisman; J K Errick; M W Lo
Journal:  Ann Emerg Med       Date:  1986-05       Impact factor: 5.721

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.